GlaxoSmithKline (GSK) confirmed in September 2024 that manufacturing operations would stop in the Cumbrian town in June 2025 with the firm also announcing they would be donating £2 million to benefit ...

Sentiment plummeted to a seven-month low as one-year inflation expectations surged to their highest point since late 2023. The US economy added 143,000 jobs in January, fewer than expected. The ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class ...

Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) reflecting updated views and recent competitive ...

Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased GSK plc. ("GSK" or the ...

You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@frankcruzlaw.com, by telephone at (310) 914-5007, or visit our website at www.frankcruzlaw.com .

GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.

The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...

GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

When drug companies manipulate the system to increase profits, patients suffer. Arizona Attorney General Kris Mayes is right ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...